Active Pharmaceutical Ingredient (API) Prequalified
M
Dolutegravir sodium (WHOAPI-445) manufactured by Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.
39th Invitation of Active Pharmaceutical Ingredients (APIs)
M
The following API was added:
23rd Invitation to Manufacturers and Suppliers of Medicinal Products for HIV Infections and Related Diseases to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The 23rd EOI for HIV/AIDS Products includes the addition of a co-pack of Cabotegravir extended-release intramuscular injection + Rilpivirine extended release intramuscular injection, as well as the
WHO prequalifies the first triple diagnostic test
IVD
WHO has granted the first prequalification listing of a bundle of three diagnostics tests to be used for pregnant women for the qualitative detection of HIV, Hepatitis B Surface Antigen, and Trepon
Active Pharmaceutical Ingredient (API) Prequalified
M
Rifampicin form I (WHOAPI-521) manufactured by Hebei Xingang Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Lupin’s pediatric abacavir/dolutegravir/lamivudine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s pediatric dispersible linezolid tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
- TB409 Linezolid 150mg dispersible - Lupin Limited – INDIA
Pediatric artemether/lumefantrine tabl from Velvet Med-Healthcare Solutions prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ pediatric rifapentine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Q2 2025 Newsletter
IVD